本次协议的签署不会导致上市公司控制权发生变更，亦未触发《上市公司收购管理办法》规定的要约收购。On November 29, 2023, humanwell healthcare (600079.SH) announced that in order to further support the healthy development of the company, maintain operational stability, and promote sustainable development, Yichang Industrial Investment Group signed the "Voting Rights Entrustment Agreement" and its supplementary agreement with Li Jie, Chen Xiaoqing, and Xu Huabin on November 29, 2024. Li Jie, Chen Xiaoqing, and Xu Huabin irrevocably, exclusively, and solely entrusted the voting rights corresponding to their holdings of 141,768,007 shares in the company (accounting for 8.69% of the total share capital, including 86,747,204 shares held by Mr. Li Jie, 43,000,087 shares held by Mr. Chen Xiaoqing, and 12,020,716 shares held by Mr. Xu Huabin) to Yichang Industrial Investment Group for exercise, with the entrustment period starting from the date of signing the "Voting Rights Entrustment Agreement" for three years.
Before this equity change, Mr. Li Jie held 86,747,204 shares of the company, accounting for 5.31% of the total share capital, with 86,747,204 shares having voting rights, also accounting for 5.31% of the total share capital; Mr. Chen Xiaoqing held 43,000,087 shares, accounting for 2.63% of the total share capital, with the same number of voting rights; Mr. Xu Huabin held 12,020,716 shares, accounting for 0.74% of the total share capital, with voting rights also accounting for 0.74% of the total share capital. Yichang Industrial Investment Group did not hold any shares of the company.
After this equity change, Mr. Li Jie held 86,747,204 shares of the company without voting rights, accounting for 5.31% of the total share capital; Mr. Chen Xiaoqing held 43,000,087 shares without voting rights, accounting for 2.63% of the total share capital; Mr. Xu Huabin held 12,020,716 shares without voting rights, accounting for 0.74% of the total share capital. Yichang Industrial Investment Group did not hold any shares of the company and exercised the voting rights corresponding to a total of 141,768,007 shares, accounting for 8.69% of the total share capital.
The signing of this agreement will not lead to a change in the control of the listed company, nor does it trigger the mandatory offer stipulated in the "Measures for the Administration of Takeovers of Listed Companies."
